The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Feasibility of circulating tumour cell (CTC) enumeration and molecular profiling (MP) as a biomarker in advanced endometrial cancer (aEC).
Charlotte Rose Lemech
No relevant relationships to disclose
Leah Ensell
No relevant relationships to disclose
Jennifer Paterson
No relevant relationships to disclose
Gemma Eminowicz
No relevant relationships to disclose
Helen Lowe
No relevant relationships to disclose
Natalie Griffin
No relevant relationships to disclose
Rupali Arora
No relevant relationships to disclose
Hendrik-Tobias Arkenau
No relevant relationships to disclose
Martin Widschwendter
No relevant relationships to disclose
Nicola MacDonald
No relevant relationships to disclose
Adeola Olaitan
No relevant relationships to disclose
Tim Mould
No relevant relationships to disclose
Tim Meyer
No relevant relationships to disclose
John Anthony Hartley
No relevant relationships to disclose
Anita Mitra
No relevant relationships to disclose
Jonathan A. Ledermann
No relevant relationships to disclose
Mary McCormack
No relevant relationships to disclose
Rebecca Sophie Kristeleit
No relevant relationships to disclose